Clinical trials - Press Releases

Date	Title	Company
30-Jul-2020	New data in NEJM shows nirsevimab reduced respiratory syncytial virus infections (lower respiratory tract infections) requiring medical care in healthy premature infants	sanofi
30-Jul-2020	GAMA Healthcare Bolsters Science and Innovation Team with Four New Hires	GAMA Healthcare
30-Jul-2020	Biotech Vico Therapeutics raises $31 million (€27 million) in Series A financing round to advance therapies for rare central nervous system diseases	Vico Therapeutics
30-Jul-2020	Acacia Pharma Advances Preparations for US Launch of BARHEMSYS®	Acacia Pharma Group plc
30-Jul-2020	Oculis Announces Successful End-of-Phase 2 Meeting with the FDA for OCS-01 in Two Ophthalmology Indications	Oculis
30-Jul-2020	New clinical study shows heat combined with TENS provides 32% reduction in chronic pain	OMRON Healthcare Europe
30-Jul-2020	Results of Grifols’ AMBAR clinical trial published in Alzheimer's & Dementia: The Journal of The Alzheimer’s Association	AMBAR
30-Jul-2020	SAVORTEX RESPONDS TO COVID-19 WITH LAUNCH OF REVOLUTIONARY NEW ‘SMART’ HAND SANITISER	SAVORTEX
30-Jul-2020	Jubilant Biosys Limited announces the merger with Jubilant Chemsys Limited	Jubilant Biosys Limited
30-Jul-2020	Aetion and Cegedim Health Data announce new partnership to power real-world evidence research in Europe	Aetion
30-Jul-2020	European Commission grants marketing authorisation for world’s first subcutaneous formulation of infliximab, Remsima® SC, for an additional five indications including for use in inflammatory bowel disease and ankylosing spondylitis	Celltrion Healthcare
28-Jul-2020	Zsolt Lavotha has been appointed acting CEO of Swedish Biomimetics 3000® Ltd	Swedish Biomimetics 3000®
28-Jul-2020	Chiesi publishes its annual report: Group generates almost €2 billion turnover and obtains B Corp certification in 2019	Chiesi Group
28-Jul-2020	Update on Phase 2b clinical study of lead asset XF-73 in the prevention of post-surgical bacterial infections	Destiny Pharma plc
28-Jul-2020	Fund+ Leads EUR38 Million Series B Financing in Indigo Diabetes NV	Fund+
28-Jul-2020	Oculis Announces Successful End-of-Phase 2 Meeting with the FDA for OCS-01 in Two Ophthalmology Indications	Oculis
28-Jul-2020	CPI, the Cell and Gene Therapy Catapult and MicrofluidX announce development of technology to rapidly scale up cell and gene therapy manufacture	CPI
28-Jul-2020	European Commission grants marketing authorisation for world’s first subcutaneous formulation of infliximab, Remsima® SC, for an additional five indications including for use in inflammatory bowel disease and ankylosing spondylitis	Celltrion Healthcare
28-Jul-2020	Chi-Med and Lilly to Collaborate in Commercializing Elunate® in China	Chi-Med
28-Jul-2020	Chi-Med’s NDA for Savolitinib in Non-Small Cell Lung Cancer Granted Priority Review in China	Chi-Med